Binding characteristics of the 5‐HT2A receptor antagonists altanserin and MDL 100907
- 3 October 2005
- Vol. 58 (4), 249-257
- https://doi.org/10.1002/syn.20205
Abstract
To study the 5‐HT2A receptors in the living human brain, using positron emission tomography (PET), two selective radiotracers are currently in use: [18F]altanserin and [11C]MDL 100907. It is, however, currently unknown to what extent data obtained with either tracer are directly comparable. The aim of this study was to compare binding characteristics of these two radiotracers in rat brain with respect to affinity (Kd), receptor binding density (Bmax), binding potential (BP), and nonspecific binding. Further, binding kinetics, sensitivity towards competition with the endogenous transmitter serotonin, and the competitive/noncompetitive interaction between the two radioligands were evaluated. In addition, the selectivity of [18F]altanserin for the 5‐HT2A receptor was assessed. The Kd value of [18F]altanserin and [3H]MDL 100907 was in the order of 0.3 nM. Bmax in frontal cortex was 523 and 527 fmol/mg protein, respectively. The binding of [18F]altanserin was not influenced by blocking either the 5‐HT2B/2C or the α1‐adrenergic receptors. At 37°C the association t1/2 was 2.8 and 2.7 min and the dissociation t1/2 was 11 and 13.5 min for [18F]altanserin and [3H]MDL 100907, respectively. Both radioligands were displaced by 5‐HT, only at high concentrations; the Ki value of 5‐HT ranging between 650 and 3,300 nM. This indicates that binding of both radioligands in PET studies is not directly influenced by changes in endogenous 5‐HT. Overall, the binding of [18F]altanserin and [3H]MDL 100907 to the 5‐HT2A receptor was very comparable, showing selective high affinity binding in the subnanomolar range. Synapse 58:249–257, 2005.Keywords
This publication has 43 references indexed in Scilit:
- [18F]altanserin Binding to Human 5HT2A Receptors is Unaltered after Citalopram and Pindolol ChallengeJournal of Cerebral Blood Flow & Metabolism, 2004
- Fenfluramine evokes 5-HT2A receptor-mediated responses but does not displace [11C]MDL 100907: Small animal PET and gene expression studiesSynapse, 2003
- Quantification of 5-HT2A Receptors in the Human Brain Using [18F]Altanserin-PET and the Bolus/Infusion ApproachJournal of Cerebral Blood Flow & Metabolism, 2003
- Expression of serotonin 5‐HT2A receptors in the human cerebellum and alterations in schizophreniaSynapse, 2001
- Analyses of [18F]altanserin bolus injection PET data. II: Consideration of radiolabeled metabolites in humansSynapse, 2001
- A review of the role of serotonin receptors in psychiatric disordersHuman Psychopharmacology: Clinical and Experimental, 2000
- Kinetic Analysis of the 5-HT2A Ligand [11C]MDL 100,907Journal of Cerebral Blood Flow & Metabolism, 2000
- [11C]MDL 100907, a radioligand for selective imaging of 5-HT2A receptors with positron emission tomographyLife Sciences, 1996
- Drug‐receptor dissociation time, new tool for drug research: Receptor binding affinity and drug‐receptor dissociation profiles of serotonin‐S2, Dopamine‐D2, histamine‐H1 antagonists, and opiatesDrug Development Research, 1986
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973